|
![]() |
pseudoephedrine sulfateThis page contains recent news articles, when available, and an overview of pseudoephedrine sulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.36 Pseudoephedrine (as Sulfate): 30 mg Pseudoephedrine Sulfate.................................. 155 60 mg Pseudoephedrine Sulfate. ... Pay-Per-View - Federal Register 2006 - Loislaw United States Code of Federal Regulations - 21 CFR § 341.80 Labeling... - Jul 11, 2006 ...(ii) For products containing phenylephrine hydrochloride, pseudoephedrine hydrochloride, pseudoephedrine sulfate, or phenylephrine bitartrate identified in ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw FDA Approvals: Clarinex, Abilify, Isovorin - Mar 10, 2005 March 10, 2005 — The US Food and Drug Administration (FDA) has approved desloratadine 5 mg plus pseudoephedrine sulfate 240 mg extended-release tablets for ... Medscape Press Release: FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine … - Feb 1, 2006 PR Newswire; December 4, 1998 ; 700+ words ... ... pseudoephedrine sulfate) Extended Release Tablets. The new CLARITIN-D 24 Hour Tablets ... rhinitis who ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Watson Pharmaceuticals Named Exclusive Distributor of ... - Oct 18, 2005 PR Newswire; September 24, 2004 ; 700+ words ... ... and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg (24-Hour Formulation ... and ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: INVEGA(R) Receives Positive Opinion From European … - Apr 27, 2007 PR Newswire; September 24, 2004 ; 700+ words ... ... and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg (24-Hour Formulation ... and ... Pay-Per-View - PR Newswire - HighBeam Research Aerospan, Clarinex-D 12-hour tablets.(New & Approved) - Apr 1, 2006 Clarinex-D 12-Hour Extended-Release Tablets (desloratadine 2.5 mg and pseudoephedrine sulfate 120 mg, Schering Plough Corp.) ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Merger and Acquisition Scenario - Mar 11, 2006 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Extended Release; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate. Cardiovascular System ... $250.00 - Revere Reports - Revere Federal Register 2007 - 72 FR 8184 Withdrawal of Approval of 128 … - Feb 23, 2007 CP2 Pseudoephedrine Sulfate 120 mg ------------------------------------------------------------------------ 85P-0147/ Ketoconazole 20 mg/mL Janssen ... Pay-Per-View - Federal Register 2007 - Loislaw Press Release: FDA Approves CLARINEX-D(R) 24 HOUR Prescription- … - Mar 4, 2005 ...and Drug Administration (FDA) has approved CLARINEX-D(R) 24 HOUR (desloratadine 5mg and pseudoephedrine sulfate USP 240 mg) Extended Release Tablets for ... Pay-Per-View - PR Newswire - HighBeam Research Vigo meth ordinance runs into problems with state law - Apr 23, 2008 Vigo's 2004 ordinance targets ephedrine, pseudoephedrine, ephedrine hydrochloride, pseudoephedrine hydrochloride, pseudoephedrine sulfate and ... Terre Haute Tribune Star Competitors by Product Report - Aug 2, 2008 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride ... $75.00 - Revere Reports - Revere United States Code of Federal Regulations - 21 CFR § 310.545 Drug … - Jul 11, 2006 ...alkaloids Euphorbia pilulifera Metaproterenol sulfate Methoxyphenamine hydrochloride Pseudoephedrine hydrochloride Pseudoephedrine sulfate Theophylline, ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw Competitors by Product Report - Aug 2, 2008 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride ... $75.00 - Revere - Alacra Store New formulations.(drug approvals)(Brief Article) - Apr 4, 2005 From Schering-Plough, Kenilworth, NJ, (908) 298-4000, Clarinex-D 24 Hour (desloratadine 5 mg and pseudoephedrine sulfate USP 240 mg) Extended Release ... Free with registration - Drug Topics - AccessMyLibrary.com Competitors by Product Report - Oct 4, 2008 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride ... $75.00 - Revere - Alacra Store FDA Approves CLARINEX-D(R) 24 HOUR Prescription-Strength Once- … - Mar 4, 2005 ...and Drug Administration (FDA) has approved CLARINEX-D(R) 24 HOUR (desloratadine 5mg and pseudoephedrine sulfate USP 240 mg) Extended Release Tablets for ... RedOrbit Competitors by Product Report - Mar 29, 2008 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride ... $75.00 - Revere Reports - Revere FDA Approves Clarinex-D 12 Hour (Desloratadine/Pseudoephedrine) … - Feb 2, 2006 ...today announced that the US Food and Drug Administration (FDA) has approved Clarinex-D® 12 hour (desloratadine 2.5 mg and pseudoephedrine sulfate, ... DG News Newly Published Study Demonstrates NASONEX(R) (Mometasone … - Dec 13, 2005 ...syrup and RediTabs(R) and CLARINEX-D(R) 24 HOUR (desloratadine 5mg/pseudoephedrine sulfate USP 240 mg) Extended Release Tablets. ... Free with registration - PR Newswire - AccessMyLibrary.com FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/ … - Feb 6, 2006 SGP) today announced that the US Food and Drug Administration (FDA) has approved CLARINEX-D® 12 HOUR (desloratadine 2.5 mg and pseudoephedrine sulfate, ... Medical News Today - Medical News Today (press release) Seasonal Allergic Rhinitis - FDA Approves CLARINEX-D Gel 24 HOUR … - Mar 5, 2005 ...and Drug Administration (FDA) has approved CLARINEX-D(R) 24 HOUR (desloratadine 5mg and pseudoephedrine sulfate USP 240 mg) Extended Release Tablets for ... Medical News Today - Medical News Today (press release) Competitors by Product Report - Mar 29, 2008 Schering-Plough Corporation (SGP) Products:. Afrin Series (Oxymetazoline); Drixoral Nasal Decongestant (Pseudoephedrine Sulfate) ... $75.00 - Revere Reports - Revere Clarinex-D 24 Hour extended release tablets approved by the FDA.( … - Jul 1, 2005 The FDA has recently approved Clarinex-D 24 Hour (desloratadine 5 mg and pseudoephedrine sulfate USP 240 mg) extended release tablets to treat nasal and ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com No 483 for Cardinal Health, process validation issue observed.(Human ... - Jun 1, 2005 ...found blend uniformity samples taken from the drums did not meet the RSD or assay specification for chlorphenirarmne maleate or pseudoephedrine sulfate. ... Free with registration - Validation Times - AccessMyLibrary.com Clarinex-D 12 Hour.(drug approval for allergic rhinitis)(Brief... - Apr 1, 2006 Clarinex-D 12 Hour (desloratadine 2.5-mg/pseudoephedrine sulfate 120-mg extended-release tablets) has been approved for the treatment of nasal and non-nasal ... Free with registration - Patient Care for the Nurse Practitioner - AccessMyLibrary.com OT-Cs earn more prominent role.(MERCHANDISING)(Consumer … - Oct 30, 2006 ...as well as in combination with pseudoephedrine sulfate, were approved as OTC drugs. That led to the release of such products as Claritin and Claritin-D. Free with registration - MMR - AccessMyLibrary.com FDA approves Clarinex-D[R] 12 Hour.(PIPELINE PREVIEWS) - Apr 1, 2006 The FDA recently approved Clarinex-D 12 Hour (deslorati-dine 2.5 mg and pseudoephedrine sulfate, USP 120 mg) Extended Release Tablets for the treatment of ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Article: Fluzone, Clarinex-D 24 hour.(New & Approved) - Family... - Apr 15, 2005 Administration approval for manufacturing and marketing of Loratadine and Pseudoephedrine Sulfate Extended-release tablets. The extended-release tablets, ... Pay-Per-View - Family Practice News - HighBeam Research United States Code of Federal Regulations - 21 CFR § 341.20 Nasal … - Jul 11, 2006 ...(3) Pseudoephedrine sulfate. (4) Phenylephrine bitartrate in an effervescent dosage form. (b) Topical nasal decongestants. (1) Levmetamfetamine. ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw FDA clears SP's Clarinex 24 Hour.(Schering-Plough)(Brief Article) - Mar 14, 2005 The US Food and Drug Administration has cleared drugmaker Schering-Plough's Clarinex-D 24-hour (desloratadine 5mg/pseudoephedrine sulfate USP 240mg) ... $4.95 - Pharma Marketletter - ECNext Competitors by Product Report - Sep 30, 2006 Products:. Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Extended Release ... $75.00 - Revere Reports - Revere Ohio Administrative Code - 4725-16-02 Additional oral therapeutic … - Aug 16, 2005 ...hydrochloride (8) Fexofenadine/pseudoephedrine (9) Amoxicillin/clavulante potassium (10) Loratadine and pseudoephedrine sulfate (11) Azthromycin up to ... Pay-Per-View - Ohio Administrative Code - Loislaw Research Shows Patients With Allergic Rhinitis Prefer NASONEX(R) ( … - Sep 6, 2005 ...(desloratadine) syrup and tablets and CLARINEX-D(R) 24 HOUR (desloratadine 5mg and pseudoephedrine sulfate USP 240 mg) Extended Release Tablets. ... $4.95 - PR Newswire - ECNext Allergy and Immunology; FDA approves CLARINEX-D 24 hour - Apr 5, 2005 ...(SGP) announced that the US Food and Drug Administration (FDA) has approved CLARINEX-D 24 hour (desloratadine 5 mg and pseudoephedrine sulfate USP 240 mg) ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Merger and Acquisition Scenario - Oct 21, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Allergy and Immunology; FDA approves CLARINEX-D 24 hour - Apr 8, 2005 ...(SGP) announced that the US Food and Drug Administration (FDA) has approved CLARINEX-D 24 hour (desloratadine 5 mg and pseudoephedrine sulfate USP 240 mg) ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Sep 2, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 9, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 28, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 13, 2006 Loratadine/Pseudoephedrine Extended Release; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals Metoprolol Succinate ... $250.00 - Revere Reports - Revere New formulations. - Mar 6, 2006 Clarinex-D 12 Hour Extended Release Tablets (desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg) have approval for the relief of nasal and ... $9.94 - Drug Topics - Alacra Store Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 3, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 28, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Drug/Medical Device - Sep 30, 2006 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate, Relief Of Allergic Rhinitis, Chronic Idiopathic Urticaria, Headache, Fatigue, Dry Mouth, ... $70.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere New formulation of Nasonex.(PRODUCTS)(Brief Article) | Article from … - Apr 1, 2005 The tablets combine desloratadine (2.5 mg) with pseudoephedrine sulfate (120 mg). For more information, contact Schering-Plough Corp. by calling ... Pay-Per-View - Internal Medicine News - HighBeam Research Merger and Acquisition Scenario - Apr 15, 2006 Loratadine/Pseudoephedrine Extended Release; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals Metoprolol Succinate ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 29, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 30, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Article: OT-Cs earn more prominent role.(MERCHANDISING)(Consumer … - Oct 30, 2006 ...well as in combination with pseudoephedrine sulfate, were approved as O-T-C drugs. That led to the release of such products as Claritin and Claritin-D. ... Pay-Per-View - MMR - HighBeam Research Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Company Profile Report - Sep 30, 2006 Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Extended Release. Cardiovascular System ... $50.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 14, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 14, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 11, 2006 Loratadine/Pseudoephedrine Extended Release; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals Metoprolol Succinate ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet; Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate; Andrx Pharmaceuticals ... $250.00 - Revere Reports - Revere |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |